phosphate and L-aspartate in the de novo pyrimidine biosynthetic pathway. Escherichia coli ATCase, an allosteric enzyme (1, 2), is a 303-kDa molecule that can be dissociated into two catalytic trimers and three regulatory dimers (3-6). Lipscomb and his associates (7-9) have determined the three-dimensional structure of E. coli ATCase in both R ("relaxed") and T ("taut") allosteric conformations. Bacillus subtilis ATCase, a trimer of 34-kDa catalytic chains that lacks regulatory chains, resembles the isolated E. coli ATCase catalytic trimer (10). Lerner and Switzer (11) 
mammalian ATCase domain and the prokaryotic enzymes have virtually identical active-site residues and are likely to have the same tertiary fold.
CPS/7-GLN 9.1kb .>Psti DHO phosphate and L-aspartate in the de novo pyrimidine biosynthetic pathway. Escherichia coli ATCase, an allosteric enzyme (1, 2) , is a 303-kDa molecule that can be dissociated into two catalytic trimers and three regulatory dimers (3) (4) (5) (6) . Lipscomb and his associates (7) (8) (9) have determined the three-dimensional structure of E. coli ATCase in both R ("relaxed") and T ("taut") allosteric conformations. Bacillus subtilis ATCase, a trimer of 34-kDa catalytic chains that lacks regulatory chains, resembles the isolated E. coli ATCase catalytic trimer (10) . Lerner and Switzer (11) sequenced the B. subtilis ATCase gene and showed that it is homologous to the E. coli catalytic chain.
The structural organization of mammalian ATCase is distinctly different. The ATCase activity is carried by a domain of a 240-kDa multifunctional polypeptide (12) (13) (14) . This protein, called CAD, also has carbamoyl-phosphate synthetase (CPSase II, EC 6.3.5.5) and dihydroorotase (DHOase, EC 3.5.2.3) activities. In mammals CPSase II is an allosteric enzyme, whereas ATCase is unregulated (15 GA GE CM AT GTG AM GT A MC C E0 OG GIG GIG CIG  GG GAG GT GC TAT MTC GAT GEG CMG GTG TlG GIA COC E   gly tyr gly gln asp val arg lys trp pro gln gly ala val pro gln pro pro pro ser ala pro ala thr thr glu ile thr thr thr   GE   TAT GG CAA GAT GIA CGG AM 2G OCT CM 3G GET GIT   CM   OGC aCC OCT TCA GCT OCT GC ACC A GA ATA (21) were calculated by using BIONET. Molecular weights and pI values were calculated by using the IBI sequence analysis programs. CAD was isolated from hamster cell line 165-23, kindly provided by George Stark (Imperial Cancer Research Fund, London), as described previously (14) . The ATCase domain generated by controlled proteolysis with elastase or trypsin (protein/protease weight ratio, 100) was isolated on a CMSephadex column (16) and its purity was checked by SDS/ PAGE (22) and by assaying ATCase activity (23) . A Waters Pico-Tag system with precolumn phenyl isothiocyanate derivatization (24) was used for amino acid analysis. Automated Edman degradation was performed on a gas-phase sequenator. The molecular weight and Stokes radius were determined by gel filtration (25) on a calibrated Sephadex G-200 column.
RESULTS
The nucleotide sequence of a region that maps from about 4.8 to 5.8 kb of the 6.5-kb cDNA insert of pCAD142 ( Fig. 2) was Upper half of the matrix gives number of amino acid identities;
lower half gives percent identities based on the common length of the pair. References and abbreviations are given in Fig. 3 determined. We also confirmed the published sequence (17) , which extends 456 nucleotides further downstream to the stop codon. We sequenced all of this region but not both strands. Our data agreed with the published sequence except that we found a guanine instead of an adenine in the third position of the codon for Gln-240 in CAD (see Fig. 3 
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Rt OTC FL C on the amino terminus. The molecular weight of the domain plus the amino-terminal extension was calculated to be 36,249. This value is about 10% lower than the observed value. Isoelectric focusing of the isolated domain gave a pI of 9.4 (16) , close to the value of 9.8 calculated from the amino acid sequence. The amino acid composition of the isolated domain was similar to that calculated from the sequence ( Table 2) . Except for histidine and methionine, which gave erratic, low values, the average difference between the observed and deduced composition was 7%. The oligomeric structure ofthe isolated domain determined by gel filtration (Fig. 4) showed that the undenatured protein suggests that the basically the same. The structural homology was also reerial proteins are flected in similar hydrophilic profiles (Fig. 5) .
Assuming that the mammalian domain and the E. coli
Case domain, E.
catalytic chain have similar tertiary structures, all of the MTCase insertions and deletions mapped to the surface of the monocoli B. subtilist mer and occurred outside regions of well-defined secondary structure (Fig. 6 ). The sole exception was a single amino acid deletion in an a-helix at position 183. The residues involved 13,000 33, 500 in substrate binding and catalysis in the E. coli enzyme (7-9) 13,943 34,185 were found to be conserved in the CAD sequence ( (28, 29) ; kinetic data (34); other properties (3, 6) . (9) ; CAD residues are from sequence homology (Fig. 3) . DISCUSSION
Nucleotide sequence analysis combined with further characterization of the protein disclosed that mammalian ATCase is remarkably similar to its prokaryotic counterparts. The mammalian domain and E. coli catalytic chain are the same size (34 kDa), share 44% amino acid sequence identity, and have nearly superimposable hydropathic profiles. Edman degradation of the isolated domain precisely defined its amino terminus, while the hydrodynamic studies established that it associates into compactly folded trimers. The virtual identity of active-site residues and the similarity in kinetic parameters suggest that the E. coli and CAD enzymes have similar catalytic mechanisms. A trimeric structure is required for the activity of the E. coli enzyme because the active site is composed of residues from adjacent polypeptide chains (catalytic subunits C1 and C2) (8, 37) . We conclude that the ATCase domain in CAD must associate as trimers and thus participate in the formation of the higher oligomers (10, 38) . Only 52% (27 of 52) of the residues involved in the E. coli trimeric (C1-C2) contacts (7) (8) (9) are conserved in the CAD sequence, suggesting that significant remodeling of this interface has occurred, perhaps as a result of the loss of allosteric control in the mammalian enzyme. Ofthe 25 C1-C2 residues not conserved in CAD, 20 are also different in B. subtilis ATCase, which like the CAD ATCase domain is a trimeric, unregulated enzyme.
The ATCase and DHOase domains are connected by a 133-residue chain segment that is highly susceptible to proteases. In addition to elastase and trypsin, we found that five other proteases cleave the linker first, although the size of the resulting ATCase domain varies somewhat (data not shown). On the basis of differences in the sizes of the fragments produced by trypsin and Staphylococcus aureus V8 protease, Rumsby et al. (39) estimated that the protease-sensitive region might be as large as 100 amino acids, a value close to that found in the sequencing study.
The isolated ATCase and DHOase domains are fully active even though most of the connecting chain segment has been removed during the proteolytic digestion (18, 40) . It is therefore unlikely that the linker is required for catalysis. Allosteric control persists long after the proteolytic cleavage of the ATCase and DHOase domains, so that the allosteric ligands probably do not bind in this region of the molecule. Phosphorylation site 2 was thought by Carrey et al. (27) to be less critical to regulation than site 1. Its location in the linker region, far from the regulated CPSase domain in a highly accessible region ideal for adventitious reaction with the kinase, supports this interpretation. [Carrey and Hardie (41) correctly identified the location of phosphorylation site 1 but were uncertain of the location of site 2. Sequence analysis shows that site 2 is in the DHOase-ATCase linker and probably corresponds to the minor phosphorylation site 3 postulated by those authors.]
An intriguing possibility is that the linker may be important for the metabolic compartmentation of intermediates (42) . A long interdomain chain segment may be necessary to bring the CPSase and ATCase domains, located at opposite ends of the polypeptide, into close proximity. The linker is long enough to span the 100-A monomer (38) 
